↓ Skip to main content

Dove Medical Press

Article Metrics

What is this page? Embed badge

The cost of schizophrenia in Japan

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
67 Mendeley
Summary Twitter Facebook Dimensions citations
Title
The cost of schizophrenia in Japan
Published in
Neuropsychiatric Disease and Treatment, May 2013
DOI 10.2147/ndt.s41632
Pubmed ID
23785238
Authors

Mitsuhiro Sado, Ataru Inagaki, Akihiro Koreki, Knapp, Lee Andrew Kissane, Mimura, Kimio Yoshimura

Abstract

Schizophrenia is a disorder that produces considerable burdens due to its often relapsing/remitting or chronic longitudinal course. This burden is felt not only by patients themselves, but also by their families and health care systems. Although the societal burden caused by this disorder has been evaluated in several countries, the magnitude of the societal cost of schizophrenia in Japan has never been estimated. The aim of this study is to clarify the societal burden of schizophrenia by estimating the cost of schizophrenia in Japan in 2008.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 27%
Student > Bachelor 10 15%
Student > Master 7 10%
Student > Ph. D. Student 5 7%
Student > Doctoral Student 3 4%
Other 8 12%
Unknown 16 24%
Readers by discipline Count As %
Medicine and Dentistry 10 15%
Economics, Econometrics and Finance 10 15%
Psychology 9 13%
Agricultural and Biological Sciences 5 7%
Nursing and Health Professions 4 6%
Other 7 10%
Unknown 22 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2013.
All research outputs
#12,684,199
of 22,711,242 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,135
of 2,974 outputs
Outputs of similar age
#95,660
of 192,823 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#18
of 53 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,974 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.

This page is hosted by Altmetric on behalf of Dove Medical Press.